Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS)
CNY 68.99
(-0.95%)
CNY 68.99
(-0.95%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 403.17 Million CNY | -92.67% |
| 2022 | 5.53 Billion CNY | 94.95% |
| 2021 | 2.83 Billion CNY | 63.19% |
| 2020 | 1.73 Billion CNY | 502.39% |
| 2019 | 288.79 Million CNY | 25.18% |
| 2018 | 230.7 Million CNY | 23.18% |
| 2017 | 187.28 Million CNY | 45.02% |
| 2016 | 129.14 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 90.63 Million CNY | 4.99% |
| 2024 Q2 | 86.32 Million CNY | -5.26% |
| 2024 Q1 | 91.11 Million CNY | -29.41% |
| 2023 FY | 405.5 Million CNY | -92.67% |
| 2023 Q1 | 94.05 Million CNY | -92.42% |
| 2023 Q2 | 92.56 Million CNY | -1.59% |
| 2023 Q4 | 129.07 Million CNY | 43.71% |
| 2023 Q3 | 89.81 Million CNY | -2.96% |
| 2022 Q4 | 1.24 Billion CNY | 20.8% |
| 2022 Q3 | 1.02 Billion CNY | -41.08% |
| 2022 Q2 | 1.74 Billion CNY | 14.6% |
| 2022 FY | 5.53 Billion CNY | 94.95% |
| 2022 Q1 | 1.52 Billion CNY | 128.11% |
| 2021 Q3 | 1.04 Billion CNY | 279.98% |
| 2021 Q1 | 856.51 Million CNY | 34.03% |
| 2021 FY | 2.83 Billion CNY | 63.19% |
| 2021 Q4 | 667.16 Million CNY | -35.93% |
| 2021 Q2 | 274.04 Million CNY | -68.0% |
| 2020 Q3 | 528.11 Million CNY | 41.9% |
| 2020 Q2 | 372.16 Million CNY | 85.74% |
| 2020 Q1 | 200.37 Million CNY | 104.08% |
| 2020 FY | 1.73 Billion CNY | 502.39% |
| 2020 Q4 | 639.02 Million CNY | 21.0% |
| 2019 FY | 288.79 Million CNY | 25.18% |
| 2019 Q4 | 98.18 Million CNY | 43.45% |
| 2019 Q3 | 68.44 Million CNY | -0.67% |
| 2019 Q1 | 53.26 Million CNY | -26.23% |
| 2019 Q2 | 68.9 Million CNY | 29.38% |
| 2018 Q4 | 72.19 Million CNY | 17.43% |
| 2018 FY | 230.7 Million CNY | 23.18% |
| 2018 Q3 | 61.47 Million CNY | 0.0% |
| 2017 FY | 187.28 Million CNY | 45.02% |
| 2016 FY | 129.14 Million CNY | 0.0% |